Literature DB >> 2925239

Oral administration of a streptococcal antigen coupled to cholera toxin B subunit evokes strong antibody responses in salivary glands and extramucosal tissues.

C Czerkinsky1, M W Russell, N Lycke, M Lindblad, J Holmgren.   

Abstract

Generation of local and systemic immune responses by the oral administration of antigens is frequently inefficient, requiring large quantities of immunogens and yielding only modest antibody responses. In this study, we have demonstrated that oral administration of microgram amounts of Streptococcus mutans protein antigen I/II covalently coupled to the B subunit of cholera toxin elicits vigorous mucosal as well as extramucosal immunoglobulin A and G antistreptococcal antibody responses in mice. These responses were manifested by the presence of large numbers of antibody-secreting cells in salivary glands, mesenteric lymph nodes, and spleens and by the development of high levels of circulating antibodies. This novel immunization strategy may find broad application in the construction of oral vaccines for the control of infectious diseases caused by pathogens encountered at mucosal and extramucosal sites.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2925239      PMCID: PMC313231          DOI: 10.1128/iai.57.4.1072-1077.1989

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  33 in total

1.  Evidence for a common mucosal immunologic system. I. Migration of B immunoblasts into intestinal, respiratory, and genital tissues.

Authors:  M R McDermott; J Bienenstock
Journal:  J Immunol       Date:  1979-05       Impact factor: 5.422

Review 2.  Actions of cholera toxin and the prevention and treatment of cholera.

Authors:  J Holmgren
Journal:  Nature       Date:  1981-07-30       Impact factor: 49.962

3.  Protein antigens of Streptococcus mutans: purification and properties of a double antigen and its protease-resistant component.

Authors:  M W Russell; L A Bergmeier; E D Zanders; T Lehner
Journal:  Infect Immun       Date:  1980-05       Impact factor: 3.441

4.  Development of improved cholera vaccine based on subunit toxoid.

Authors:  J Holmgren; A M Svennerholm; I Lönnroth; M Fall-Persson; B Markman; H Lundbeck
Journal:  Nature       Date:  1977-10-13       Impact factor: 49.962

5.  Origin and differentiation of lymphocytes involved in the secretory IgA responses.

Authors:  J J Cebra; P J Gearhart; R Kamat; S M Robertson; J Tseng
Journal:  Cold Spring Harb Symp Quant Biol       Date:  1977

6.  Organ and isotype distribution of plasma cells producing specific antibody after oral immunization: evidence for a generalized secretory immune system.

Authors:  P Weisz-Carrington; M E Roux; M McWilliams; J M PHILLIPS-Quagliata; M E Lamm
Journal:  J Immunol       Date:  1979-10       Impact factor: 5.422

7.  Receptor-specific large-scale purification of cholera toxin on silica beads derivatized with lysoGM1 ganglioside.

Authors:  J L Tayot; J Holmgren; L Svennerholm; M Lindblad; M Tardy
Journal:  Eur J Biochem       Date:  1981-01

8.  Detection of IgA anti-Escherichia coli plasma cells in the intestine and salivary glands of pigs orally and locally infected with E. coli.

Authors:  E V De Buysscher; P R Dubois
Journal:  Adv Exp Med Biol       Date:  1978       Impact factor: 2.622

9.  Protein thiolation and reversible protein-protein conjugation. N-Succinimidyl 3-(2-pyridyldithio)propionate, a new heterobifunctional reagent.

Authors:  J Carlsson; H Drevin; R Axén
Journal:  Biochem J       Date:  1978-09-01       Impact factor: 3.857

10.  The role of antigen form and function in the primary and secondary intestinal immune responses to cholera toxin and toxoid in rats.

Authors:  N F Pierce
Journal:  J Exp Med       Date:  1978-07-01       Impact factor: 14.307

View more
  78 in total

1.  Anti-class II monoclonal antibody-targeted Vibrio cholerae TcpA pilin: modulation of serologic response, epitope specificity, and isotype.

Authors:  J Y Wu; R K Taylor; W F Wade
Journal:  Infect Immun       Date:  2001-12       Impact factor: 3.441

2.  Cholera toxin B subunit as a carrier molecule promotes antigen presentation and increases CD40 and CD86 expression on antigen-presenting cells.

Authors:  A George-Chandy; K Eriksson; M Lebens; I Nordström; E Schön; J Holmgren
Journal:  Infect Immun       Date:  2001-09       Impact factor: 3.441

3.  Generation of female genital tract antibody responses by local or central (common) mucosal immunization.

Authors:  H Y Wu; S Abdu; D Stinson; M W Russell
Journal:  Infect Immun       Date:  2000-10       Impact factor: 3.441

4.  Intranasal immunization against dental caries with a Streptococcus mutans-enriched fimbrial preparation.

Authors:  M Fontana; A J Dunipace; G K Stookey; R L Gregory
Journal:  Clin Diagn Lab Immunol       Date:  1999-05

5.  Cholera toxin B-subunit gene enhances mucosal immunoglobulin A, Th1-type, and CD8+ cytotoxic responses when coadministered intradermally with a DNA vaccine.

Authors:  Alba E Sanchez; Guillermo Aquino; Pedro Ostoa-Saloma; Juan P Laclette; Leticia Rocha-Zavaleta
Journal:  Clin Diagn Lab Immunol       Date:  2004-07

Review 6.  Mucosal immunity: overcoming the barrier for induction of proximal responses.

Authors:  Brent S McKenzie; Jamie L Brady; Andrew M Lew
Journal:  Immunol Res       Date:  2004       Impact factor: 2.829

Review 7.  Oral immunization using live attenuated Salmonella spp. as carriers of foreign antigens.

Authors:  L Cárdenas; J D Clements
Journal:  Clin Microbiol Rev       Date:  1992-07       Impact factor: 26.132

8.  Treatment of experimental autoimmune encephalomyelitis by feeding myelin basic protein conjugated to cholera toxin B subunit.

Authors:  J B Sun; C Rask; T Olsson; J Holmgren; C Czerkinsky
Journal:  Proc Natl Acad Sci U S A       Date:  1996-07-09       Impact factor: 11.205

9.  Cholera toxin B-subunit gene fusion: structural and functional analysis of the chimeric protein.

Authors:  M T Dertzbaugh; D L Peterson; F L Macrina
Journal:  Infect Immun       Date:  1990-01       Impact factor: 3.441

10.  Oral immunization with recombinant Salmonella typhimurium expressing surface protein antigen A of Streptococcus sobrinus: persistence and induction of humoral responses in rats.

Authors:  T K Redman; C C Harmon; S M Michalek
Journal:  Infect Immun       Date:  1994-08       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.